ClinVar Genomic variation as it relates to human health
NM_000548.5(TSC2):c.1149del (p.Ile383fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000548.5(TSC2):c.1149del (p.Ile383fs)
Variation ID: 2810243 Accession: VCV002810243.1
- Type and length
-
Deletion, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 2061900 (GRCh38) [ NCBI UCSC ] 16: 2111901 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 20, 2024 Feb 20, 2024 Oct 27, 2022 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000548.5:c.1149del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000539.2:p.Ile383fs frameshift NM_001077183.3:c.1149del NP_001070651.1:p.Ile383fs frameshift NM_001114382.3:c.1149del NP_001107854.1:p.Ile383fs frameshift NM_001318827.2:c.1038del NP_001305756.1:p.Ile346fs frameshift NM_001318829.2:c.1002del NP_001305758.1:p.Ile334fs frameshift NM_001318831.2:c.549del NP_001305760.1:p.Ile183fs frameshift NM_001318832.2:c.1182del NP_001305761.1:p.Ile394fs frameshift NM_001363528.2:c.1149del NP_001350457.1:p.Ile383fs frameshift NM_001370404.1:c.1149del NP_001357333.1:p.Ile383fs frameshift NM_001370405.1:c.1149del NP_001357334.1:p.Ile383fs frameshift NM_001406663.1:c.1149del NP_001393592.1:p.Ile383fs frameshift NM_001406664.1:c.1149del NP_001393593.1:p.Ile383fs frameshift NM_001406665.1:c.1149del NP_001393594.1:p.Ile383fs frameshift NM_001406667.1:c.1239del NP_001393596.1:p.Ile413fs frameshift NM_001406668.1:c.1239del NP_001393597.1:p.Ile413fs frameshift NM_001406670.1:c.1038del NP_001393599.1:p.Ile346fs frameshift NM_001406671.1:c.1137del NP_001393600.1:p.Ile379fs frameshift NM_001406673.1:c.1137del NP_001393602.1:p.Ile379fs frameshift NM_001406675.1:c.1002del NP_001393604.1:p.Ile334fs frameshift NM_001406676.1:c.1002del NP_001393605.1:p.Ile334fs frameshift NM_001406677.1:c.1092del NP_001393606.1:p.Ile364fs frameshift NM_001406678.1:c.1038del NP_001393607.1:p.Ile346fs frameshift NM_001406679.1:c.1002del NP_001393608.1:p.Ile334fs frameshift NM_001406680.1:c.549del NP_001393609.1:p.Ile183fs frameshift NM_001406681.1:c.687del NP_001393610.1:p.Ile229fs frameshift NM_001406682.1:c.549del NP_001393611.1:p.Ile183fs frameshift NM_001406683.1:c.549del NP_001393612.1:p.Ile183fs frameshift NM_001406684.1:c.549del NP_001393613.1:p.Ile183fs frameshift NM_001406685.1:c.549del NP_001393614.1:p.Ile183fs frameshift NM_001406686.1:c.549del NP_001393615.1:p.Ile183fs frameshift NM_001406687.1:c.549del NP_001393616.1:p.Ile183fs frameshift NM_001406688.1:c.549del NP_001393617.1:p.Ile183fs frameshift NM_001406689.1:c.-196del 5 prime UTR NM_001406690.1:c.-196del 5 prime UTR NM_001406691.1:c.-196del 5 prime UTR NM_001406692.1:c.-196del 5 prime UTR NM_001406693.1:c.-196del 5 prime UTR NM_001406694.1:c.-164del 5 prime UTR NM_001406695.1:c.-164del 5 prime UTR NM_001406696.1:c.-196del 5 prime UTR NM_001406697.1:c.-196del 5 prime UTR NM_001406698.1:c.-372del 5 prime UTR NM_021055.3:c.1149del NP_066399.2:p.Ile383fs frameshift NR_176225.1:n.1259del non-coding transcript variant NR_176226.1:n.1259del non-coding transcript variant NR_176227.1:n.1259del non-coding transcript variant NR_176228.1:n.1259del non-coding transcript variant NR_176229.1:n.1259del non-coding transcript variant NC_000016.10:g.2061900del NC_000016.9:g.2111901del NG_005895.1:g.17595del LRG_487:g.17595del LRG_487t1:c.1149del LRG_487p1:p.Ile383Metfs - Protein change
- I364fs, I229fs, I346fs, I383fs, I413fs, I183fs, I334fs, I379fs, I394fs
- Other names
- -
- Canonical SPDI
- NC_000016.10:2061899:C:
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
-
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
TSC2 | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
10625 | 10800 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (1) |
criteria provided, single submitter
|
Oct 27, 2022 | RCV003627815.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 27, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Tuberous sclerosis 2
Affected status: unknown
Allele origin:
germline
|
Invitae
Accession: SCV004409752.1
First in ClinVar: Feb 20, 2024 Last updated: Feb 20, 2024 |
Comment:
For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with TSC2-related conditions. … (more)
For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with TSC2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ile383Metfs*6) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. | Au KS | Genetics in medicine : official journal of the American College of Medical Genetics | 2007 | PMID: 17304050 |
Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. | Jones AC | American journal of human genetics | 1999 | PMID: 10205261 |
Text-mined citations for this variant ...
HelpRecord last updated Feb 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.